The extrapulmonary dissemination of tuberculosis: A meta-analysis

International Journal of Mycobacteriology

Volumn 3, Issue 1, 2014, Pages 9-16

  Webster, Andrew Scott ^a   Shandera, Wayne Xavier ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Cytokines; Dissemination; Extrapulmonary; Meta analysis; Mycobacteria; Tuberculosis

Indexed keywords

PURINERGIC P2X7 RECEPTOR;

ADULT; AGE; ARTICLE; DIABETES MELLITUS; DISEASE ASSOCIATION; EXTRAPULMONARY TUBERCULOSIS; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MALE; MILIARY TUBERCULOSIS; PRIORITY JOURNAL; SEX DIFFERENCE; SMOKING;

EID: 84897104780     PISSN: 22125531     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijmyco.2014.01.003     Document Type: Article

References (48)

1. Kong Y., Cave M.D., Zhang L., et al. Association between Mycobacterium tuberculosis Beijing/W lineage strain infection and extrathoracic tuberculosis: insights from epidemiologic and clinical characterization of the three principal genetic groups of M. tuberculosis clinical isolates. J. Clin. Microbiol. 2007, 45(2):409-414.
2. Pethe K., Alonso S., Biet F., et al. The heparin-binding haemagglutinin of M. tuberculosis is required for extrapulmonary dissemination. Nature 2001, 412(6843):190-194.
3. CDC, Reported tuberculosis in the United States, 2012, CDC, Atlanta, 2013.
4. WHO, Global tuberculosis report, 2012, WHO, France, 2012.
5. Glaziou P., Falzon D., Floyd K., et al. Global epidemiology of tuberculosis. Semin. Respir. Crit. Care Med. 2013, 34(1):3-16.
6. Gonzalez O.Y., Adams G., Teeter L.D., et al. Extra-pulmonary manifestations in a large metropolitan area with a low incidence of tuberculosis. Int. J. Tuberc. Lung Dis. 2003, 7(12):1178-1185.
7. El-Sadr W.M., Tsiouris S.J. HIV-associated tuberculosis: diagnostic and treatment challenges. Semin. Respir. Crit. Care Med. 2008, 29(5):525-531.
8. Kipp A.M., Stout J.E., Hamilton C.D., et al. Extrapulmonary tuberculosis, human immunodeficiency virus, and foreign birth in North Carolina, 1993-2006. BMC Public Health 2008, 8:107.
9. Sayarlioglu M., Inanc M., Kamali S., et al. Tuberculosis in Turkish patients with systemic lupus erythematosus: increased frequency of extrapulmonary localization. Lupus 2004, 13(4):274-278.
10. Al-Arif L.I., Goldstein R.A., Affronti L.F., et al. HLA-Bw15 and tuberculosis in a North American black population. Am. Rev. Respir. Dis. 1979, 120(6):1275-1278.
11. STATA, STATA 11C, StataCorp, College Station, TX, (11) 2009.
12. STATA Meta-Analysis in Stata: An Updated Collection from the STATA Journal 2009, Stata Press Publication, College Station, TX.
13. Hawn T.R., Dunstan S.J., Thwaites G.E., et al. A polymorphism in Toll-interleukin 1 receptor domain containing adaptor protein is associated with susceptibility to meningeal tuberculosis. J. Infect. Dis. 2006, 194(8):1127-1134.
14. Henao M.I., Montes C., Paris S.C., et al. Cytokine gene polymorphisms in Colombian patients with different clinical presentations of tuberculosis. Tuberculosis 2006, 86(1):11-19.
15. Motsinger-Reif A.A., Antas P.R., Oki N.O., et al. Polymorphisms in IL-1beta, vitamin D receptor Fok1, and Toll-like receptor 2 are associated with extrapulmonary tuberculosis. BMC Med. Genet. 2010, 11:37.
16. Wilkinson R.J., Patel P., Llewelyn M., et al. Influence of polymorphism in the genes for the interleukin (IL)-1 receptor antagonist and IL-1beta on tuberculosis. J. Exp. Med. 1999, 189(12):1863-1874.
17. Caws M., Thwaites G., Dunstan S., et al. The influence of host and bacterial genotype on the development of disseminated disease with Mycobacterium tuberculosis. PLoS Pathog. 2008, 4(3):e1000034.
18. Shah P., El-Maaytah M., Jerjes W., et al. Interleukin 12 receptor beta1 chain deficiency in a child with disseminated tuberculosis: a case report. J. Oral. Maxillofac. Surg. 2010, 68(4):909-911.
19. Dalgic N., Tekin D., Kayaalti Z., et al. Arg753Gln polymorphism of the human Toll-like receptor 2 gene from infection to disease in pediatric tuberculosis. Hum. Immunol. 2011, 72(5):440-445.
20. Ma X., Liu Y., Gowen B.B., et al. Full-exon resequencing reveals toll-like receptor variants contribute to human susceptibility to tuberculosis disease. PLoS ONE 2007, 2(12):e1318.
21. Thuong N.T., Hawn T.R., Thwaites G.E., et al. A polymorphism in human TLR2 is associated with increased susceptibility to tuberculous meningitis. Genes Immun. 2007, 8(5):422-428.
22. Ganachari M., Ruiz-Morales J.A., Gomez de la Torre Pretell J.C., et al. Joint effect of MCP-1 genotype GG and MMP-1 genotype 2G/2G increases the likelihood of developing pulmonary tuberculosis in BCG-vaccinated individuals. PLoS ONE 2010, 5(1):8881-8890.
23. Hasan Z., Jamil B., Khan J., et al. Relationship between circulating levels of IFN-gamma, IL-10, CXCL9 and CCL2 in pulmonary and extrapulmonary tuberculosis is dependent on disease severity. Scand. J. Immunol. 2009, 69(3):259-267.
24. Fitness J., Floyd S., Warndorff D.K., et al. Large-scale candidate gene study of tuberculosis susceptibility in the Karonga district of northern Malawi. Am. J. Trop. Med. Hyg. 2004, 71(3):341-349.
25. Soborg C., Andersen A.B., Range N., et al. Influence of candidate susceptibility genes on tuberculosis in a high endemic region. Mol. Immunol. 2007, 44(9):2213-2220.
26. van Crevel R., Parwati I., Sahiratmadja E., et al. Infection with Mycobacterium tuberculosis Beijing genotype strains is associated with polymorphisms in SLC11A1/NRAMP1 in Indonesian patients with tuberculosis. J. Infect. Dis. 2009, 200(11):1671-1674.
27. Ben Selma W., Harizi H., Bougmiza I., et al. Interferon gamma +874T/A polymorphism is associated with susceptibility to active pulmonary tuberculosis development in Tunisian patients. DNA Cell Biol. 2011, 30(6):379-387.
28. Cailhol J., Decludt B., Che D. Sociodemographic factors that contribute to the development of extrapulmonary tuberculosis were identified. J. Clin. Epidemiol. 2005, 58(10):1066-1071.
29. Garcia-Rodriguez J.F., Alvarez-Diaz H., Lorenzo-Garcia M.V., et al. Extrapulmonary tuberculosis: epidemiology and risk factors. Enferm. Infecc. Microbiol. Clin. 2011, 29(7):502-509.
30. Kadivar M.R., Ghaneh-Shirazi R., Khavandegaran F., et al. Epidemiology of tuberculosis among Afghan immigrants in Fars province, southern Islamic Republic of Iran. East. Mediterr. Health J. 2007, 13(4):758-764.
31. Musellim B., Erturan S., Sonmez Duman E., et al. Comparison of extra-pulmonary and pulmonary tuberculosis cases: factors influencing the site of reactivation. Int. J. Tuberc. Lung Dis. 2005, 9(11):1220-1223.
32. Ong A., Creasman J., Hopewell P.C., et al. A molecular epidemiological assessment of extrapulmonary tuberculosis in San Francisco. Clin. Infect. Dis. 2004, 38(1):25-31.
33. Peto H.M., Pratt R.H., Harrington T.A., et al. Epidemiology of extrapulmonary tuberculosis in the United States, 1993-2006. Clin. Infect. Dis. 2009, 49(9):1350-1357.
34. Rasolofo Razanamparany V., Menard D., Auregan G., et al. Extrapulmonary and pulmonary tuberculosis in Antananarivo (Madagascar): high clustering rate in female patients. J. Clin. Microbiol. 2002, 40(11):3964-3969.
35. Torgersen J., Dorman S.E., Baruch N., et al. Molecular epidemiology of pleural and other extrapulmonary tuberculosis: a Maryland state review. Clin. Infect. Dis. 2006, 42(10):1375-1382.
36. Zhang X., Andersen A.B., Lillebaek T., et al. Effect of sex, age, and race on the clinical presentation of tuberculosis: a 15-year population-based study. Am. J. Trop. Med. Hyg. 2011, 85(2):285-290.
37. Noertjojo K., Tam C.M., Chan S.L., et al. Extra-pulmonary and pulmonary tuberculosis in Hong Kong. Int. J. Tuberc. Lung Dis. 2002, 6(10):879-886.
38. Fernando S.L., Saunders B.M., Sluyter R., et al. A polymorphism in the P2X7 gene increases susceptibility to extrapulmonary tuberculosis. Am. J. Respir. Crit. Care Med. 2007, 175(4):360-366.
39. Taype C.A., Shamsuzzaman S., Accinelli R.A., et al. Genetic susceptibility to different clinical forms of tuberculosis in the Peruvian population. Infect. Genet. Evol. 2010, 10(4):495-504.
40. Ben-Selma W., Harizi H., Boukadida J. Association of TNF-alpha and IL-10 polymorphisms with tuberculosis in Tunisian populations. Microbes Infect. 2011, 13(10):837-843.
41. Ogus A.C., Yoldas B., Ozdemir T., et al. The Arg753GLn polymorphism of the human toll-like receptor 2 gene in tuberculosis disease. Eur. Respir. J. 2004, 23(2):219-223.
42. Mosaad Y.M., Soliman O.E., Tawhid Z.E., et al. Interferon-gamma +874 T/A and interleukin-10-1082 A/G single nucleotide polymorphism in Egyptian children with tuberculosis. Scand. J. Immunol. 2010, 72(4):358-364.
43. Vallinoto A.C., Graca E.S., Araujo M.S., et al. IFNG+874T/A polymorphism and cytokine plasma levels are associated with susceptibility to Mycobacterium tuberculosis infection and clinical manifestation of tuberculosis. Hum. Immunol. 2010, 71(7):692-696.
44. W.X. Shandera, A. Karstaedt, G. Land, et al., Immunogenetic HLA loci associated with disseminated tuberculosis, Presented at 6th IAS Conference on HIV Pathogenesis, Treatment, and Prevention, July 2011, Rome, Italy, 2011.
45. Donald P.R., Schaaf H.S., Schoeman J.F. Tuberculous meningitis and miliary tuberculosis: the Rich focus revisited. J. Infect. 2005, 50(3):193-195.
46. Kempainen R., Nelson K., Williams D.N., et al. Mycobacterium tuberculosis disease in Somali immigrants in Minnesota. Chest 2001, 119(1):176-180.
47. Nisar M., Williams C.S., Davies P.D. Experience of tuberculosis in immigrants from South East Asia-implications for the imminent lease back of Hong Kong. Respir. Med. 1991, 85(3):219-222.
48. Ellner J.J. The emergence of extensively drug-resistant tuberculosis: a global health crisis requiring new interventions: part II: scientific advances that may provide solutions. Clin. Transl. Sci. 2009, 2(1):80-84.